Medicine and Dentistry
Glycon
57%
Left Ventricular Hypertrophy
55%
Mental Health
55%
Congestive Heart Failure
44%
Diabetes
37%
Coronary Artery Disease
26%
Early Intervention
24%
Diseases
24%
Lymphocyte
23%
Neutrophil
23%
Chronic Kidney Disease
18%
Heart Failure with Preserved Ejection Fraction
18%
Heart Failure with Reduced Ejection Fraction
18%
Secondary Prevention
18%
Ischemic Heart Disease
18%
Primary Percutaneous Coronary Intervention
18%
Randomized Controlled Trial
18%
Diabetic Cardiomyopathy
18%
COVID-19
18%
Clinical Intervention
18%
Early Psychosis
18%
Medical Science
18%
Patient Care
18%
Cost-Effectiveness Analysis
18%
Early Intervention in Psychosis
18%
Proteomics
18%
Antiinflammatory Activity
18%
Insulin Resistance
18%
Health Care Cost
12%
Cognitive Behavioral Therapy
12%
Recurrence Risk
12%
Family Therapy
12%
Cardiovascular System
10%
Placebo
10%
Comorbidity
8%
Adverse Outcome
7%
Maturity Onset Diabetes of the Young
7%
Oxidative Stress
7%
Drug Therapy
6%
Drug Abuse
6%
Mental Health Service
6%
Social Participation
6%
Recommended Drug Dose
6%
Positive Syndrome
6%
Haloperidol
6%
Pediatrician
6%
Olanzapine
6%
Risperidone
6%
General Practitioner
6%
Peer Group
6%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Metformin
57%
Heart Left Ventricle Hypertrophy
55%
Heart Ventricle Remodeling
37%
Placebo
31%
Coronary Artery Disease
26%
Dapagliflozin
23%
Acute Heart Failure
23%
Diabetes Mellitus
23%
Randomized Controlled Trial
20%
Heart Failure with Reduced Ejection Fraction
18%
Ischemic Heart Disease
18%
Ivabradine
18%
Cotransporter
18%
Adverse Outcome
18%
Antiinflammatory Activity
18%
Diabetic Cardiomyopathy
18%
Risperidone
18%
Olanzapine
18%
Pharmacotherapy
18%
Heart Failure with Preserved Ejection Fraction
18%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
18%
Nitric Acid Derivative
18%
Insulin Resistance
18%
Non Insulin Dependent Diabetes Mellitus
16%
Inflammation
9%
Loop Diuretic Agent
7%
Respiratory Tract Disease
6%
Disease Severity
6%
Comorbidity
6%
Kidney Disease
6%
Cardiovascular Disease
6%
Biological Marker
5%
Arginine
5%
Proteome
5%
Pyruvic Acid
5%
Glutathione
5%
Proline
5%
Impaired Glucose Tolerance
5%
Antidiabetic Agent
5%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
5%
Cytokine
5%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
34%
Neutrophil-To-Lymphocyte Ratio
18%
Mass Spectrometry
18%
Proteomics
18%
Antiinflammatory Activity
18%
Matrix-Assisted Laser Desorption/Ionization
18%
Cytokine
12%
Metabolic Pathway
12%
Arginine
12%
AMP-activated Protein Kinase
12%
Proteome
12%
Sulfonylurea
12%
Kinase
12%
Proline
12%
Phosphotransferase
12%
Gluconeogenesis
6%
Chemokine
6%
Tumor Necrosis Factor
6%
Electrospray Ionization
6%
Interleukin 6
6%
Mediator
6%
Heart Ventricle Function
6%
Tandem Mass Spectrometry
6%
Proinflammatory Cytokine
6%
Glutathione Metabolism
6%
Macrophage
6%
Hepatocyte
6%
Interleukin-1
6%
Gene Ontology
6%
Secretion (Process)
6%
Tandem Mass Spectrometry
6%
Gene Expression
6%
Protein-Protein Interaction Networks
6%
Glutathione
6%
